Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 2:20 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 6,038 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity Clear all

Conditions: Overweight and Obesity, Elevated Triglycerides
Interventions: Full-fat fermented dairy, Low-fat fermented dairy, Non-dairy, non-fermented foods; Other
Lead sponsor: Midwest Center for Metabolic and Cardiovascular Research; Other
Eligibility: 18 Years to 74 Years
Enrollment: 110 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 4
States / cities: Miami Gardens, Florida • Chicago, Illinois • Gurnee, Illinois

Conditions: Physical Fitness, Obesity, Child Development, Growth
Interventions: Not listed
Lead sponsor: University of California, Irvine; Other
Eligibility: 8 Years to 18 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004
U.S. locations: 1
States / cities: Orange, California

Conditions: Obesity, Overweight, or Chronic Weight Management
Interventions: aleniglipron or placebo; Drug
Lead sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics; Industry
Eligibility: 18 Years to 79 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 11
States / cities: Phoenix, Arizona • Chicago, Illinois • Richfield, Minnesota + 8 more

Conditions: Obesity, Obesity; Drug, Overweight or Obesity, Weight Loss, Weight Loss Trajectory, Weight, Body
Interventions: Semaglutide 2.4mg, Placebo; Drug
Lead sponsor: Loma Linda University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Obesity
Interventions: lorcaserin hydrochloride XR, Placebo; Drug
Lead sponsor: Eisai Inc.; Industry
Eligibility: 12 Years to 17 Years
Enrollment: 278 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 16
States / cities: Phoenix, Arizona • Bell Gardens, California • Long Beach, California + 13 more

Conditions: Obesity
Interventions: Traditional food; Other
Lead sponsor: Alaska Native Tribal Health Consortium; Other
Eligibility: 0 Years and older
Enrollment: 416 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Anchorage, Alaska

Conditions: Overweight, Obesity
Interventions: Lifestyle Counseling; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 276 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Childhood Obesity
Interventions: SmartMeal application, Distributed points of sale, Staff wellness curriculum; Behavioral
Lead sponsor: University of California, Berkeley; Other
Eligibility: Not listed
Enrollment: 27,406 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 24
States / cities: San Francisco, California

Conditions: Breast Cancer
Interventions: Letrozole, Fish Oil; Drug · Dietary Supplement
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Houston, Texas • San Antonio, Texas

Conditions: Obesity
Interventions: Tigecycline; Drug
Lead sponsor: Manjunath Prakash Pai; Other
Eligibility: 18 Years to 50 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Albany, New York

Conditions: Autism Spectrum Disorder, Obesity, Childhood, Autism
Interventions: PBT-A, Health Education (HE); Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 6 Years to 12 Years
Enrollment: 140 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Obesity, Cardiovascular Diseases
Interventions: Diet, Exercise, Environment; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 3,938 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Prader Willi Syndrome, Syndromic Obesity, Childhood Obesity
Interventions: Low Carbohydrate diet, Low Fat diet; Other
Lead sponsor: Duke University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obese Hypogonadotropic Hypogonadism
Interventions: Investigational new drug company code: BGS649, Placebo; Drug
Lead sponsor: Mereo BioPharma; Industry
Eligibility: 30 Years to 65 Years · Male only
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 4
States / cities: Tucson, Arizona • San Diego, California • Miramar, Florida + 1 more

Conditions: Autism, Obesity
Interventions: Parent Education Program, Manual-based Behavioral Treatment; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 3 Years to 10 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Obesity and Overweight, HIV, Chronic Inflammation
Interventions: Tirzepatide; Drug
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Obesity
Interventions: JITAI Enhanced Education Intervention Option, JITAI Self-Efficacy Intervention Option, JITAI Motivation Intervention Option, JITAI Self-Regulation Intervention Option, JITAI Generic Risk Alert Intervention Option (Active Comparator), Online Behavioral Obesity Treatment, JITAI No Treatment Intervention Option; Behavioral
Lead sponsor: The Miriam Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Obesity
Interventions: Low carbohydrate; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 21 Years to 50 Years
Enrollment: 69 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity, Thinness, Weight Gain
Interventions: Not listed
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 25 Years to 35 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit, Risk Reduction
Interventions: Semi Quantitative Food Frequency Questionnaire (SQFFQ); Behavioral
Lead sponsor: San Raffaele University; Other
Eligibility: 18 Years to 49 Years
Enrollment: 2,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2035
U.S. locations: 2
States / cities: Denver, Colorado • Chicago, Illinois

Conditions: Obesity
Interventions: Propofol and Fentanyl administration; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obesity, Airway Complication of Anesthesia, Intubation; Difficult or Failed
Interventions: endotracheal intubation; Procedure
Lead sponsor: Zeliha Alicikus; Government
Eligibility: 18 Years and older
Enrollment: 223 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Jacksonville, Florida

Conditions: Obesity
Interventions: 6-month educational program, 6-month standard care program; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Atherosclerosis, Stress, Hypertension, Dyslipidemias, Obesity, Diabetes, Coronary Artery Disease
Interventions: Resilience, Stress, and Ethnicity (RiSE); Behavioral
Lead sponsor: Loyola University; Other
Eligibility: 25 Years to 75 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Maywood, Illinois

Search by objective public record fields.

A Trial to Assess Full-fat or Low-fat Dairy Foods on Insulin Sensitivity, RBC FA's and Other Markers of Metabolic Health

Exercise Changes to Peripheral Blood Mononuclear Cells in Children

Aleniglipron Phase 2 Body Composition Study

Latino Semaglutide Study

Study to Evaluate the Efficacy and Safety of Belviq XR® in Conjunction With Lifestyle Modification for Weight Loss in Obese Adolescents, Age 12 to 17 Years

Back to Basics: Addressing Childhood Obesity Through Traditional Foods in Alaska

LIVE SMART: Smartphone Intervention for Weight Control

Technology and Design Innovation for School Lunch

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects

Family, Responsibility, Education, Support, and Health for Families With a Child With Autism

Workplace-Sponsored Program to Reduce Obesity

Prader-Willi Syndrome Macronutrient Study

Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men

Development of a Manual-based, Interdisciplinary Intervention for Youth With ASD and Obesity

Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIV

Miro-randomized Trial for Optimizing a JITAI to Reduce Dietary Lapses in Obesity Treatment

Intramuscular Lipid and Insulin Action:Ethnic Aspects

The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity

Peri-Intubation Adverse Airway Events in Critically Ill Patients With Morbid and Super Obesity

Obesity Assessment and Education Through the Internet

RiSE to Prevent Cardiovascular Disease in African Americans